Balyasny Asset Management »

Disc Medicine shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $758k 15k 49.14
2024-06-30 $463k 10k 45.07

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Energy (XLE)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
salesforce Call Option (CRM)
Home Depot Call Option (HD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
FMR
BlackRock
OrbiMed Advisors
Frazier Life Sciences Management
Paradigm Biocapital Advisors
Wellington Management Company
T. Rowe Price Associates
Henderson Group
Vanguard Group
Bain Capital Life Sciences Investors
State Street Corporation
Citadel Advisors
Deerfield Management Company
Saturn V Capital Management

View all funds holding Disc Medicine